Bone Marrow Diseases  >>  Cilcane (cilengitide)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cilcane (cilengitide) / Iceni Pharma
NCT00004258: EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Completed
1
40
US
cilengitide
Indiana University School of Medicine, National Cancer Institute (NCI)
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific
08/01
09/01

Download Options